Compare 10X Genomics Inc (TXG) vs Western Union Co (WU) Price & Performance

10x Genomics (TXG) trades at $77.28, down 4.19% on the day, amid a bearish technical signal. The company reported revenue of $642.82M in 2025, with a net loss of $43.54M, though it has beaten EPS estimates for three consecutive quarters. Recent news highlights the launch of its Atera spatial biology platform and a patent victory, signaling innovation and market strength. Cash flow from operations improved to $136.05M in 2025, indicating better operational efficiency.

The outlook is cautiously optimistic, with strong product demand and improving margins offering upside potential. However, persistent losses, high valuation multiples, and competitive pressures present significant risks. Analyst consensus is mixed, with a $74.30 price target slightly below the current price, reflecting uncertainty about near-term profitability.

Western Union (WU) trades at $6.33, up 3.09% with bearish technical signals but attractive valuation metrics including a P/E of 4.93 and P/S of 0.48. Recent earnings show mixed performance with two misses in the last three quarters, while the company maintains strong profitability with 9.79% net margin and 43.97% ROE. The $200 million Beyond Efficiency Plan and pending Intermex acquisition represent key strategic initiatives amid declining revenue trends from $4.5B in 2022 to $4.0B projected for 2026.

WU presents a value opportunity with deep valuation discounts but faces significant headwinds including revenue contraction and integration risks from the Intermex acquisition. Analyst sentiment remains cautious with only 12% buy ratings, though the $6.86 consensus target offers 8% upside. The stock's appeal hinges on successful cost-cutting execution and digital transformation amid competitive pressures in money transfer services.